About this FactMed analysis covering adverse side effect reports of CANCIDAS patients who developed FORMICATION.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking CANCIDAS reported FORMICATION to the FDA. A total of 2464 CANCIDAS drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between CANCIDAS and FORMICATION. In doing so, we compare CANCIDAS with other drugs that cause FORMICATION, to help you evaluate whether or not CANCIDAS causes FORMICATION. Likewise, this page shows the most highly-reported side effects of CANCIDAS, so you can see if FORMICATION ranks among CANCIDAS's most well-known side effects.
Summary Statistics
Reports of CANCIDAS causing FORMICATION: 1
Reports of any side effect of CANCIDAS : 2464
Percentage of CANCIDAS patients where FORMICATION is a reported side effect: 0.0406%

FDA reports of any drug causing FORMICATION : 2415
Average percentage for all medicated patients where FORMICATION is reported as a complication: 0.0151%

Physician opinion on CANCIDAS as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing CANCIDAS:
ASPERGILLOSIS ( 188 patients )
CANDIDIASIS ( 181 patients )
FUNGAL INFECTION ( 169 patients )
BRONCHOPULMONARY ASPERGILLOSIS ( 120 patients )
SYSTEMIC CANDIDA ( 92 patients )
PYREXIA ( 88 patients )
DRUG USE FOR UNKNOWN INDICATION ( 51 patients )
SEPSIS ( 41 patients )
FEBRILE NEUTROPENIA ( 29 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 29 patients )
ANTIFUNGAL PROPHYLAXIS ( 29 patients )
OESOPHAGEAL CANDIDIASIS ( 26 patients )
PROPHYLAXIS ( 25 patients )
INFECTION ( 23 patients )
EVIDENCE BASED TREATMENT ( 21 patients )
FUNGAEMIA ( 19 patients )
PNEUMONIA ( 15 patients )
LUNG INFECTION ( 15 patients )
SYSTEMIC MYCOSIS ( 14 patients )
CANDIDA SEPSIS ( 14 patients )
ANTIFUNGAL TREATMENT ( 13 patients )
ENDOCARDITIS ( 13 patients )
INFECTION PROPHYLAXIS ( 13 patients )
FUNGAL SEPSIS ( 12 patients )
SEPTIC SHOCK ( 11 patients )
PNEUMONIA FUNGAL ( 10 patients )
ENDOCARDITIS CANDIDA ( 7 patients )
URINARY TRACT INFECTION FUNGAL ( 7 patients )
NEUTROPENIA ( 7 patients )
ORAL CANDIDIASIS ( 7 patients )
RESPIRATORY MONILIASIS ( 7 patients )
RESPIRATORY TRACT INFECTION FUNGAL ( 7 patients )
FUNGAL ENDOCARDITIS ( 6 patients )
ACUTE MYELOID LEUKAEMIA ( 5 patients )
STEM CELL TRANSPLANT ( 5 patients )
BLOOD CULTURE POSITIVE ( 5 patients )
PELVIC ABSCESS ( 4 patients )
PERITONITIS ( 4 patients )
BACTERIAL INFECTION ( 4 patients )
ZYGOMYCOSIS ( 4 patients )
SYSTEMIC ANTIFUNGAL TREATMENT ( 4 patients )
LOWER RESPIRATORY TRACT INFECTION FUNGAL ( 4 patients )
CANDIDA PNEUMONIA ( 3 patients )
TORULOPSIS INFECTION ( 3 patients )
HIV INFECTION ( 3 patients )
ABDOMINAL SEPSIS ( 3 patients )
SEPTIC EMBOLUS ( 3 patients )
LOCALISED INFECTION ( 3 patients )
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC ( 3 patients )
ABDOMINAL INFECTION ( 3 patients )
PNEUMONIA ASPERGILLUS ( 3 patients )
DEVICE RELATED INFECTION ( 3 patients )
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME ( 3 patients )
GASTROINTESTINAL CANDIDIASIS ( 2 patients )
LUNG NEOPLASM ( 2 patients )
ENTEROBACTER INFECTION ( 2 patients )
MUCORMYCOSIS ( 2 patients )
RHINITIS ( 2 patients )
CEREBRAL FUNGAL INFECTION ( 2 patients )
BLOOD CULTURE NEGATIVE ( 2 patients )
PYONEPHROSIS ( 2 patients )
LUNG INFILTRATION ( 2 patients )
MEDIASTINITIS ( 2 patients )
CANDIDURIA ( 2 patients )
URINARY TRACT INFECTION ( 2 patients )
ENTEROCOCCAL INFECTION ( 2 patients )
CEREBRAL ASPERGILLOSIS ( 2 patients )
PHAEHYPHOMYCOSIS ( 2 patients )
VAGINAL CANDIDIASIS ( 2 patients )
MYCOSIS FUNGOIDES ( 2 patients )
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS ( 2 patients )
BACTEROIDES INFECTION ( 2 patients )
FEBRILE BONE MARROW APLASIA ( 2 patients )
ACUTE LYMPHOCYTIC LEUKAEMIA ( 2 patients )
PNEUMONIA PRIMARY ATYPICAL ( 2 patients )
BREAST CANCER ( 2 patients )
ORAL FUNGAL INFECTION ( 2 patients )
PANCREATITIS ( 1 patients )
ASPERGILLOMA ( 1 patients )
RESPIRATORY FAILURE ( 1 patients )
GRAFT INFECTION ( 1 patients )
UPPER RESPIRATORY FUNGAL INFECTION ( 1 patients )
ASPERGILLUS TEST POSITIVE ( 1 patients )
MEDICATION ERROR ( 1 patients )
RESPIRATORY TRACT INFECTION ( 1 patients )
CATHETER RELATED INFECTION ( 1 patients )
BACTERIA BLOOD IDENTIFIED ( 1 patients )
WOUND INFECTION ( 1 patients )
EYE INFECTION FUNGAL ( 1 patients )
ACUTE GRAFT VERSUS HOST DISEASE ( 1 patients )
CHOLECYSTITIS ( 1 patients )
INFECTIOUS DISEASE CARRIER ( 1 patients )
OESOPHAGEAL FISTULA ( 1 patients )
SINUSITIS FUNGAL ( 1 patients )
COCCIDIOIDOMYCOSIS ( 1 patients )
LEUKAEMIA ( 1 patients )
BRAIN ABSCESS ( 1 patients )
ANTIBIOTIC THERAPY ( 1 patients )
CYTOMEGALOVIRUS INFECTION ( 1 patients )
PSEUDALLESCHERIA INFECTION ( 1 patients )
BRONCHITIS ( 1 patients )
FUNGAL PERITONITIS ( 1 patients )
OROPHARYNGEAL CANDIDIASIS ( 1 patients )
DRUG ADMINISTRATION ERROR ( 1 patients )
LUNG DISORDER ( 1 patients )
FUNGUS SPUTUM TEST POSITIVE ( 1 patients )
PANCREAS INFECTION ( 1 patients )
ARTHRITIS BACTERIAL ( 1 patients )
RENAL TRANSPLANT ( 1 patients )
GENERAL SYMPTOM ( 1 patients )
PANCREATITIS HAEMORRHAGIC ( 1 patients )
TRICHOSPORON INFECTION ( 1 patients )
ENTERITIS INFECTIOUS ( 1 patients )
HEPATOSPLENIC CANDIDIASIS ( 1 patients )
PERITONEAL INFECTION ( 1 patients )
BACTERAEMIA ( 1 patients )
MENINGITIS ( 1 patients )
ILL-DEFINED DISORDER ( 1 patients )
BACTERIA SPUTUM IDENTIFIED ( 1 patients )
EYE INFECTION ( 1 patients )
CHOLANGITIS SUPPURATIVE ( 1 patients )
CHRONIC SINUSITIS ( 1 patients )
INFLAMMATION ( 1 patients )
OESOPHAGITIS ( 1 patients )
SKIN LESION ( 1 patients )
ANTI-INFECTIVE THERAPY ( 1 patients )
COUGH ( 1 patients )
LIVER TRANSPLANT ( 1 patients )
PULMONARY MYCOSIS ( 1 patients )
OSTEOMYELITIS ( 1 patients )
APLASIA ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with FORMICATION:

NIASPAN (164 patients)
ASPIRIN (164 patients)
SEROQUEL (162 patients)
LYRICA (145 patients)
CHANTIX (109 patients)
ZOLOFT (105 patients)
CYMBALTA (102 patients)
DURAGESIC-100 (93 patients)
XANAX (86 patients)
CLONAZEPAM (82 patients)
LIPITOR (78 patients)
FENTANYL (76 patients)
LISINOPRIL (74 patients)
OXYCONTIN (74 patients)
FOSAMAX (74 patients)
OMEPRAZOLE (72 patients)
SYNTHROID (71 patients)
EFFEXOR XR (70 patients)
PAXIL (65 patients)
NEXIUM (63 patients)
ENBREL (63 patients)
METHOTREXATE (63 patients)
HUMIRA (62 patients)
REMICADE (60 patients)
SIMVASTATIN (59 patients)
KLONOPIN (59 patients)
NEURONTIN (56 patients)
BETASERON (55 patients)
TYSABRI (55 patients)
SINGULAIR (52 patients)
AMBIEN (51 patients)
ALBUTEROL (50 patients)
SIMCOR (49 patients)
DIOVAN (49 patients)
CRESTOR (48 patients)
FENTANYL-100 (48 patients)
FOLIC ACID (47 patients)
HYDROCHLOROTHIAZIDE (47 patients)
RITUXIMAB (47 patients)
LEVAQUIN (47 patients)
PREDNISONE (46 patients)
VICODIN (45 patients)
AMITRIPTYLINE HCL (45 patients)
RIVOTRIL (44 patients)
FRONTAL (43 patients)
ATENOLOL (43 patients)
GEODON (43 patients)
TOPAMAX (43 patients)
METFORMIN HCL (41 patients)
PROZAC (40 patients)
DIAZEPAM (39 patients)
VALIUM (39 patients)
CHAMPIX (38 patients)
AMLODIPINE (37 patients)
LEVOTHYROXINE SODIUM (36 patients)
CELEXA (36 patients)
REQUIP (36 patients)
AVONEX (36 patients)
TRAZODONE HCL (35 patients)
BENADRYL (35 patients)
TRILEPTAL (35 patients)
CONCERTA (35 patients)
PROTONIX (34 patients)
LASIX (34 patients)
TOPROL-XL (34 patients)
FLUOXETINE (34 patients)
ABILIFY (33 patients)
NORVASC (33 patients)
CELEBREX (33 patients)
WELLBUTRIN (33 patients)
STRATTERA (33 patients)
MAGNEVIST (33 patients)
METHADONE HCL (32 patients)
IBUPROFEN (32 patients)
ATIVAN (32 patients)
CLONIDINE (31 patients)
ADVAIR DISKUS 100/50 (31 patients)
VIOXX (31 patients)
GABAPENTIN (31 patients)
LEXAPRO (31 patients)
PAROXETINE HCL (31 patients)
EFFEXOR (31 patients)
COPEGUS (30 patients)
PRILOSEC (30 patients)
FISH OIL (30 patients)
NAPROXEN (29 patients)
PREMARIN (29 patients)
FORTEO (29 patients)
CALCIUM (29 patients)
LORAZEPAM (29 patients)
TRAMADOL HCL (28 patients)
AVELOX (28 patients)
MORPHINE (27 patients)
PEGASYS (27 patients)
SOLU-MEDROL (27 patients)
DURAGESIC (27 patients)
ACETAMINOPHEN (26 patients)
ACTIQ (26 patients)
PERCOCET (26 patients)
PAXIL CR (25 patients)
TIBOLONE (25 patients)
ALL OTHER THERAPEUTIC PRODUCTS (25 patients)
RISPERDAL (25 patients)
METOPROLOL TARTRATE (25 patients)
PREVACID (24 patients)
PLAVIX (23 patients)
DEPAKOTE (23 patients)
SUBOXONE (23 patients)
ZETIA (23 patients)
ZOCOR (23 patients)
OXYCODONE HCL (23 patients)
LAMICTAL (22 patients)
MULTI-VITAMIN (22 patients)
COUMADIN (22 patients)
ULTRAM (21 patients)
RANITIDINE (21 patients)
ALPRAZOLAM (21 patients)
RIBAVIRIN (21 patients)
FLEXERIL (21 patients)
ZYPREXA (21 patients)
ENALAPRIL MALEATE (21 patients)
MORPHINE SULFATE (21 patients)
CITALOPRAM (20 patients)
LANSOPRAZOLE (20 patients)
BACLOFEN (20 patients)
ULTRACET (20 patients)
ZYRTEC (19 patients)
LORATADINE (19 patients)
VITAMIN D (19 patients)
PRISTIQ (19 patients)
DICLOFENAC SODIUM (19 patients)
SEROQUEL XR (19 patients)
LITHIUM CARBONATE (19 patients)
NASONEX (19 patients)
SOMA (18 patients)
METFORMIN (18 patients)
CITALOPRAM HYDROBROMIDE (18 patients)
DIGOXIN (18 patients)
LANTUS (18 patients)
PROVIGIL (18 patients)
PROFENID (17 patients)
VITAMIN B COMPLEX CAP (17 patients)
MS CONTIN (17 patients)
ALLOPURINOL (17 patients)
BEXTRA (17 patients)
FORASEQ (17 patients)
PRESSOTEC (16 patients)
ACTONEL (16 patients)
ACTOS (16 patients)
PREDNISONE TAB (16 patients)
VITAMINS (16 patients)
VOLTAREN (16 patients)
BYETTA (16 patients)
TEGRETOL (16 patients)
PHENERGAN (16 patients)
MIRAPEX (16 patients)
DORFLEX (16 patients)
FRONTAL XR (16 patients)
ATORVASTATIN CALCIUM (16 patients)
MABTHERA (16 patients)
PAROXETINE (16 patients)
BETAFERON (15 patients)
SANDOSTATIN LAR (15 patients)
REBIF (15 patients)
LEVOXYL (15 patients)
METOPROLOL (15 patients)
LORTAB (15 patients)
LOSARTAN POTASSIUM (15 patients)
WELLBUTRIN XL (15 patients)
ASCORBIC ACID (15 patients)
GABITRIL (15 patients)
AVANDIA (15 patients)
MIRENA (14 patients)
LINDANE (14 patients)
REMERON (14 patients)
VYTORIN (14 patients)
ZANAFLEX (14 patients)
SPIRIVA (14 patients)
HYDROCODONE (14 patients)
FENTANYL CITRATE (14 patients)
KETOPROFEN (14 patients)
PROVERA (14 patients)
VALTREX (14 patients)
VISTARIL (14 patients)
LOVASTATIN (13 patients)
KEPPRA (13 patients)
WELLBUTRIN SR (13 patients)
PROMETHAZINE (13 patients)
PROPRANOLOL (13 patients)
UNKNOWN GBCA (13 patients)
REGLAN (13 patients)
XYREM (13 patients)
DURAGESIC-50 (13 patients)
VITAMIN B-12 (13 patients)
LIORESAL (13 patients)
CALCIUM CARBONATE (13 patients)
INDERAL (13 patients)
DILAUDID (13 patients)
OLCADIL (13 patients)
BONIVA (13 patients)
RENAGEL (13 patients)
GLYBURIDE (13 patients)
CAPTOPRIL (12 patients)
DEPAKENE (12 patients)
PARACETAMOL (12 patients)
ETHINYL ESTRADIOL TAB (12 patients)
LENDORMIN (12 patients)
TEMAZEPAM (12 patients)
LEVONORGESTREL (12 patients)
LEVONORGESTREL AND ETHINYL ESTRADIOL (12 patients)
Most common side effects for patients taking CANCIDAS:
DRUG INEFFECTIVE (446 patients)
DEATH (215 patients)
MULTI-ORGAN FAILURE (172 patients)
SEPTIC SHOCK (149 patients)
SEPSIS (143 patients)
BRONCHOPULMONARY ASPERGILLOSIS (134 patients)
PYREXIA (125 patients)
RENAL FAILURE (102 patients)
RESPIRATORY FAILURE (99 patients)
PNEUMONIA (90 patients)
ASPERGILLOSIS (86 patients)
RENAL FAILURE ACUTE (84 patients)
FUNGAL INFECTION (76 patients)
GRAFT VERSUS HOST DISEASE (76 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (73 patients)
SYSTEMIC CANDIDA (70 patients)
CHOLESTASIS (69 patients)
DRUG INTERACTION (69 patients)
HEPATIC FAILURE (69 patients)
THROMBOCYTOPENIA (68 patients)
STEVENS-JOHNSON SYNDROME (68 patients)
HYPOTENSION (64 patients)
RASH (64 patients)
ALANINE AMINOTRANSFERASE INCREASED (63 patients)
BLOOD BILIRUBIN INCREASED (61 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (57 patients)
THERAPY NON-RESPONDER (54 patients)
PLATELET COUNT DECREASED (53 patients)
CONVULSION (53 patients)
CARDIO-RESPIRATORY ARREST (52 patients)
FEBRILE NEUTROPENIA (51 patients)
CANDIDIASIS (51 patients)
ACUTE GRAFT VERSUS HOST DISEASE (50 patients)
INFECTION (50 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (50 patients)
DRUG RESISTANCE (49 patients)
DIARRHOEA (48 patients)
CARDIAC FAILURE (47 patients)
ACUTE MYELOID LEUKAEMIA (45 patients)
PANCYTOPENIA (44 patients)
PLEURAL EFFUSION (43 patients)
TACHYCARDIA (42 patients)
NEUTROPENIA (41 patients)
ANAEMIA (41 patients)
CONDITION AGGRAVATED (40 patients)
HAEMOGLOBIN DECREASED (39 patients)
CONFUSIONAL STATE (39 patients)
SHOCK (39 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (39 patients)
CYTOLYTIC HEPATITIS (39 patients)
LIVER FUNCTION TEST ABNORMAL (39 patients)
OVERDOSE (39 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (38 patients)
TRANSAMINASES INCREASED (37 patients)
BACTERIAL INFECTION (36 patients)
COMA (36 patients)
MEDICATION ERROR (36 patients)
HAEMOPTYSIS (35 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (35 patients)
DYSPNOEA (34 patients)
TOXIC EPIDERMAL NECROLYSIS (34 patients)
PROTHROMBIN TIME PROLONGED (34 patients)
CYTOMEGALOVIRUS INFECTION (32 patients)
TREATMENT FAILURE (31 patients)
CHILLS (31 patients)
RESPIRATORY DISTRESS (30 patients)
ANURIA (30 patients)
JAUNDICE (30 patients)
COAGULOPATHY (30 patients)
CARDIAC ARREST (30 patients)
ACUTE HEPATIC FAILURE (29 patients)
HAEMORRHAGE (29 patients)
NAUSEA (28 patients)
ABDOMINAL PAIN (28 patients)
HEPATIC ENZYME INCREASED (28 patients)
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (28 patients)
HEPATITIS (28 patients)
PRURITUS (27 patients)
LEUKOPENIA (27 patients)
BLOOD CREATININE INCREASED (26 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (26 patients)
HEPATOTOXICITY (25 patients)
WHITE BLOOD CELL COUNT DECREASED (25 patients)
ADVERSE EVENT (25 patients)
GASTROINTESTINAL HAEMORRHAGE (25 patients)
HEPATIC NECROSIS (25 patients)
BLOOD UREA INCREASED (25 patients)
HYPOKALAEMIA (24 patients)
TREMOR (24 patients)
ENDOCARDITIS (23 patients)
RENAL IMPAIRMENT (23 patients)
HEADACHE (23 patients)
OEDEMA (23 patients)
OEDEMA PERIPHERAL (23 patients)
ELECTROCARDIOGRAM QT PROLONGED (23 patients)
PULMONARY HAEMORRHAGE (22 patients)
INTENTIONAL DRUG MISUSE (22 patients)
ARRHYTHMIA (22 patients)
HEPATITIS CHOLESTATIC (22 patients)
LUNG DISORDER (21 patients)
HYPERSENSITIVITY (21 patients)
FATIGUE (21 patients)
DISEASE PROGRESSION (21 patients)
RENAL TUBULAR DISORDER (21 patients)
STAPHYLOCOCCAL INFECTION (20 patients)
ORGAN FAILURE (20 patients)
PANCREATITIS (20 patients)
OESOPHAGEAL CANDIDIASIS (20 patients)
DRUG LEVEL INCREASED (20 patients)
BONE MARROW FAILURE (20 patients)
DEVICE RELATED INFECTION (20 patients)
FUNGAEMIA (20 patients)
VOMITING (19 patients)
OFF LABEL USE (19 patients)
HYPERBILIRUBINAEMIA (19 patients)
HYPOGLYCAEMIA (19 patients)
ASTHENIA (19 patients)
HYPERKALAEMIA (19 patients)
CANDIDA SEPSIS (19 patients)
SOMNOLENCE (19 patients)
ENCEPHALOPATHY (18 patients)
HEPATOMEGALY (18 patients)
NO ADVERSE EVENT (18 patients)
DERMATITIS EXFOLIATIVE (18 patients)
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED (17 patients)
AGRANULOCYTOSIS (17 patients)
NEUROPATHY (17 patients)
DRUG EFFECT DECREASED (17 patients)
ZYGOMYCOSIS (17 patients)
BRADYCARDIA (17 patients)
RHABDOMYOLYSIS (16 patients)
DISEASE RECURRENCE (16 patients)
MYOCARDITIS (16 patients)
UNDERDOSE (16 patients)
ASPERGILLOMA (16 patients)
PATHOGEN RESISTANCE (16 patients)
NO THERAPEUTIC RESPONSE (16 patients)
BLOOD SODIUM DECREASED (16 patients)
DELIRIUM (16 patients)
LUNG INFILTRATION (16 patients)
NEPHROPATHY TOXIC (15 patients)
HAEMOLYSIS (15 patients)
HYPERGLYCAEMIA (15 patients)
OLIGURIA (15 patients)
VENTRICULAR FIBRILLATION (15 patients)
ERYTHEMA (15 patients)
HAPTOGLOBIN DECREASED (15 patients)
BACTERAEMIA (15 patients)
HEPATOCELLULAR INJURY (15 patients)
LACTIC ACIDOSIS (14 patients)
HAEMATOCRIT DECREASED (14 patients)
METABOLIC ENCEPHALOPATHY (14 patients)
SYSTEMIC MYCOSIS (14 patients)
CEREBELLAR SYNDROME (14 patients)
METABOLIC DISORDER (14 patients)
HYPOCOAGULABLE STATE (14 patients)
TORSADE DE POINTES (14 patients)
HYPERTENSION (14 patients)
TOXIC SKIN ERUPTION (14 patients)
DISTURBANCE IN ATTENTION (14 patients)
CULTURE POSITIVE (14 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (13 patients)
SINUS BRADYCARDIA (13 patients)
DRUG TOXICITY (13 patients)
CHRONIC GRAFT VERSUS HOST DISEASE (13 patients)
POLYNEUROPATHY (13 patients)
STEM CELL TRANSPLANT (13 patients)
VISION BLURRED (13 patients)
RASH MACULO-PAPULAR (13 patients)
DEEP VEIN THROMBOSIS (13 patients)
HEPATIC FUNCTION ABNORMAL (13 patients)
FLUSHING (13 patients)
FUNGAL SEPSIS (13 patients)
CEREBROVASCULAR ACCIDENT (12 patients)
PEARSON'S SYNDROME (12 patients)
OSTEOPOROSIS (12 patients)
ANTITHROMBIN III DECREASED (12 patients)
ASCITES (12 patients)
COLON POLYPECTOMY (12 patients)
OSTEOARTHRITIS (12 patients)
B-CELL LYMPHOMA STAGE III (12 patients)
ENTEROCOCCAL INFECTION (12 patients)
STENOTROPHOMONAS INFECTION (12 patients)
LIVER DISORDER (12 patients)
BLOOD CULTURE POSITIVE (12 patients)
CHEST X-RAY ABNORMAL (12 patients)
RESPIRATORY MONILIASIS (12 patients)
CELLULITIS (12 patients)
ORAL CANDIDIASIS (12 patients)
LOSS OF CONSCIOUSNESS (12 patients)
VENOUS STENT INSERTION (12 patients)
VARICOSE VEIN (12 patients)
T-CELL LYMPHOMA STAGE III (12 patients)
MYDRIASIS (11 patients)
MYALGIA (11 patients)
RESPIRATORY DISORDER (11 patients)
INCORRECT DOSE ADMINISTERED (11 patients)
PERITONITIS (11 patients)
HYPOVOLAEMIC SHOCK (11 patients)
CLOSTRIDIUM DIFFICILE COLITIS (11 patients)
SEROTONIN SYNDROME (11 patients)
WEIGHT INCREASED (11 patients)
HERPES SIMPLEX (11 patients)
HAEMODIALYSIS (11 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (11 patients)
HAEMODYNAMIC INSTABILITY (11 patients)
HYPOXIA (11 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (11 patients)
DISORIENTATION (11 patients)
CAPILLARY LEAK SYNDROME (11 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for CANCIDAS


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about FORMICATION and CANCIDAS, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking CANCIDAS, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in CANCIDAS. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for CANCIDAS experts. If you are a healthcare provider experienced in prescribing CANCIDAS, please register here.

Your online appointment book for Salem Rentals & Services



© 2014 FactMed, Inc
Privacy Policy
Terms of Use